MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • June 30th, 2020 • Florida
This AGREEMENT, with an effective date as of this day of 20 , is between The University of South Florida Board of Trustees, a public body corporate, (“USF”) having an address at 3802 Spectrum Boulevard, Suite 100, Tampa, Florida 33612 and
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • December 21st, 2020
THIS AGREEMENT, entered into as of the ** day of **,**Year**, by and between **Company Name** with an office located at **Address** (hereinafter called "COMPANY"), and Format Verification Laboratory of Panasonic Corporation, having its principal place of business at 1-15 Matsuo-cho, Kadoma, Osaka 571-8504 Japan (hereinafter called "Laboratory").
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • April 23rd, 2021 • New York
This agreement (the “Agreement”) is made as of _________________________, 200_ (“Effective Date”), by and between ___________________________________________ (hereinafter referred to as "COMPANY"), a corporation duly organized under the laws of the State of ________________, and having its principal place of business at _______________________ ______________________________________________, and THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (hereinafter referred to as “FOUNDATION”), a private, nonprofit educational corporation having an office and place of business at the University at Albany, State University of New York, Office of Technology Development, University Hall Room 307, 1400 Washington Avenue, Albany, New York 12222, acting in regard to the University at Albany, State University of New York, individually called “Party,” or “Disclosing Party,” or “Receiving Party,” and collectively called “Parties.”
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • February 10th, 2023
This Mutual Confidential Disclosure Agreement (“Agreement”), effective as of (“Effective Date”), by and between Northwestern University, having offices at 633 Clark Street, Evanston, IL 60208 (“Northwestern”) and , having offices at (“Company”) (each a “Party” and collectively the “Parties”). Northwestern and Company each desire and have the authority to disclose to the other Party, and receive from the other Party, certain proprietary and confidential information (“Information”) as set forth in this Agreement. The Information developed, owned, and disclosed by Northwestern concerns (NU ) invented by . The Information developed, owned, and disclosed by Company concerns .
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • April 27th, 2017 • New York
This agreement (the “Agreement”) is made as of the date of the last signature below, (the “Effective Date”), by and between (hereinafter referred to as "Company"), a duly organized under the laws of , and having its principal place of business at
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENT –Mutual Confidential Disclosure Agreement • February 16th, 2018
, an agency of the United States Government, having a place of business with principal offices at 1600 Clifton Rd., N.E., Atlanta, Georgia, 30333 (hereinafter referred to as "CDC"), and , a corporation organized and existing under the laws of having a place of business at , (hereinafter referred to as " "), collectively referred to as the “Parties.” This Agreement shall become effective on the date when the last party to sign has executed this Agreement (“Effective Date”).
ContractMutual Confidential Disclosure Agreement • December 11th, 2019 • North Carolina
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • December 6th, 2022
This Mutual Confidential Disclosure Agreement (“Agreement”), effective as of _______________________ ___, 20___ (“Effective Date”), by and between Northwestern University, having offices at 633 Clark Street, Evanston, IL 60208 (“Northwestern”) and __________________________ having offices at ______________________________________ (“Company”) (each a “Party” and collectively the “Parties”). Northwestern and Company each desire and have the authority to disclose to the other Party, and receive from the other Party, certain proprietary and confidential information (“Information”) as set forth in this Agreement.
Mutual Confidential Disclosure AgreementMutual Confidential Disclosure Agreement • July 13th, 2018 • California
Each undersigned party (the “Receiving Party”) understands that the other party (the “Disclosing Party”) has disclosed or may disclose information relating to terms for licensing of OmniRat®,
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • August 25th, 2020 • Ontario
This Mutual Confidential Disclosure Agreement (the “Agreement”) is effective as of the date of full execution (the “Effective Date”) and is by and between MULTI-HEALTH SYSTEMS INC. addressed at 3770 Victoria Park Avenue, Toronto, Ontario, M2H 3M6, Canada (hereinafter “MHS”) and
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • December 28th, 2009 • On Semiconductor Corp • Semiconductors & related devices • Delaware
This MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENT is made to be effective on 30th day of April, 2009, between California Micro Devices Corporation , a Delaware corporation having its principal place of business at 490 N. McCarthy Blvd., #100, Milpitas, CA 95035 together with its Affiliates (the “Company”), and ON Semiconductor Corporation, a Delaware corporation having its principal place of business at 5005 East McDowell Road, Phoenix, AZ 85008 USA together with its Affiliates (“ON”). ON and the Company propose to enter into discussions concerning a corporate strategic transaction in which ON would acquire the Company via merger (a “Transaction”). In these discussions, each party (the “Discloser’”) will disclose information to the other party (the “Recipient”).
Mutual Confidential Disclosure AgreementMutual Confidential Disclosure Agreement • November 19th, 2018
NAME COMPANY/INSTITUTION, [registration number NUMBER], having its registered office at ADDRESS and duly represented by NAME, FUNCTION (the "XXXX")
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • May 30th, 2017 • Wisconsin
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • April 11th, 2024 • Novartis Ag • Pharmaceutical preparations
This Mutual Confidential Disclosure Agreement (“Agreement”), effective as of November 27, 2023 (“Effective Date”), is made and entered into between:
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENT COVERMutual Confidential Disclosure Agreement • January 22nd, 2021
WHEREAS, thisNon-Disclosure A greement responds to the parts interest to discuss a potential collaboration between UPRM and DuPont. The attached NDA is purely to open a discussion between UPRM and DuPont and know if UPRM and DuPont c_an Work Together. The NDA attached is an the complete agreement and it contains the full stipulations between the part .
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • May 19th, 2016 • Indiana
This Mutual Confidential Disclosure Agreement (“Agreement”) is made effective as of Insert Date (“Effective Date”) by and between The Trustees of Indiana University, an educational institution organized under the laws of the State of Indiana, having an address Indiana University, University Hospital, Attn: Clinical Trials Office, 410 Wet 10th Street Suite 1020, Indianapolis, IN 46202- 5167("INSTITUTION") and Insert SPONSOR Name & Address Here("SPONSOR") are interested in exchanging and evaluating certain information, which is considered confidential and proprietary ("Confidential Information"). INSTITUTION andSPONSOR (collectively referred to as the “Parties”) have agreed to exchange Confidential Information for the purpose of Insert Protocol Number: ;Insert protocol title (“Purpose”)under the following terms and conditions:
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • October 10th, 2020 • Virginia
This Mutual Confidential Disclosure Agreement (“Agreement”), effective as of ________________, 2009, is entered into by ___________________________________________________ (“Company”), a _______ corporation with offices in ______________, and Virginia Tech Intellectual Properties, Inc. (“VTIP”), a nonprofit corporation of the Commonwealth of Virginia, with offices at 2200 Kraft Drive, Suite 1050, Blacksburg, Virginia 24060, for the purpose of protecting and preserving the patent, trade secret and other proprietary rights in information to be disclosed or made available to each other under this Agreement.
MUTUAL Confidential Disclosure AgreementMutual Confidential Disclosure Agreement • April 26th, 2016 • California
This Confidential Disclosure Agreement (“Agreement”) is made and entered into as of ____________, 2016 (“Effective Date”) by and between _________________________________ having offices at _________________________________________________ (“Company”), and the Regents of the University of California, a California constitutional corporation acting on behalf of its San Francisco campus, with an address at 3333 California Street, Suite S-11, San Francisco, California 94143-1209 (“UCSF”), either a “party” in the singular or the “parties” in the plural, for the purpose of protecting certain confidential information disclosed by the parties subject to this Agreement. A party receiving confidential information shall be referred to as “Recipient” and a party disclosing confidential information shall be referred to as “Discloser.”
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • July 9th, 2013 • Delaware
In order to protect certain Confidential Information (defined below) which may be disclosed between them, the parties identified below agree as follows:
AMENDMENT NO. 3 TO MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • January 18th, 2024 • Merck Sharp & Dohme LLC • Pharmaceutical preparations
This Amendment No. 3 to Mutual Confidential Disclosure Agreement (this “Amendment No. 3”), effective as of the date of last signature below (the “Amendment No. 3 Effective Date”), confirms the mutual understanding between Merck Sharp & Dohme LLC, having a place of business at 126 East Lincoln Avenue, Rahway, New Jersey 07065, USA (“Merck”) and Harpoon Therapeutics, Inc., having a place of business at 611 Gateway Boulevard, Suite 400, South San Francisco, California 94080, USA (“Harpoon”).
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • February 1st, 2017 • Ohio
(“Company”), and THE KROGER CO., an Ohio corporation, through its Manufacturing division, having a place of business at 1014 Vine Street, Cincinnati, OH 45202 (the “Kroger”).
FIRST AMENDMENT TO MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • January 18th, 2024 • Merck Sharp & Dohme LLC • Pharmaceutical preparations
This First Amendment to the Mutual Confidential Disclosure Agreement (this “First Amendment”) is entered into as of the date of last signature below (the “First Amendment Effective Date”), by and between Merck Sharp & Dohme Corp., (“Merck”) and Harpoon Therapeutics (“Harpoon”) and amends that certain Mutual Confidential Disclosure Agreement between Merck and Harpoon, effective as of January 9th, 2020 (the “Agreement”; capitalized terms used herein without definition herein shall have the meaning given such terms in the Agreement).
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • March 14th, 2012 • Nebraska
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • November 6th, 2020 • Maine
This agreement, effective as of the last date signed below, by and between The University of Maine System, a body politic and corporate and an instrumentality and agency of the State of Maine, acting through the University of Maine’s Department of Industrial Cooperation with offices at 5717 Corbett Hall, Orono, Maine 04469, (hereinafter UMAINE) and Company Name, having offices at Company Address (hereinafter COMPANY).
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENT [NDA]Mutual Confidential Disclosure Agreement • January 6th, 2021
The term "Confidential Information" means any and all DISCLOSER business and technical information, including, without limitation, any and all specifications, drawings, software, current and future business plans, product samples and written, electronic and verbal embodiments and descriptions thereof, as well as RECIPIENT reports or analyses containing same or based thereon. Confidential Information does not include any information that is, or becomes, generally available to the public or is already in RECIPIENT’s possession.
AMENDED AND RESTATED MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • December 16th, 2019 • Merck & Co., Inc. • Pharmaceutical preparations • New York
This Amended and Restated Mutual Confidential Disclosure Agreement (this "Agreement"), effective as of the date of last signature below (the "Effective Date"), is entered into by and between Merck Sharp & Dohme Corp., having an address of 2000 Galloping Hill Road, Kenilworth, New Jersey 07033 (hereinafter referred to as "Merck") and ArQule, Inc., having an address of One Wall Street, Burlington, Massachusetts 01803 (hereinafter referred to as "ArQule") (each a "Party" and collectively, the "Parties") and sets forth the terms and conditions under which the Parties will exchange certain proprietary and confidential information/data related to ArQule's business, and its clinical pipeline of orally bioavailable product candidates, including BTK inhibitor ARQ 531 (the "Lead Compound") and Merck's interest therein (hereinafter collectively referred to as "Subject Matter").
LICENSE AGREEMENT between ASUBIO PHARMA CO., LTD. and OMEROS CORPORATIONMutual Confidential Disclosure Agreement • May 12th, 2010 • Omeros Corp • Pharmaceutical preparations • Tokyo
This license agreement (this “Agreement”) is made effective the 3rd day of March 2010 (the “Effective Date”) between Asubio Pharma Co., Ltd., a Japanese Corporation having a place of business at 9-11 Akasaka 2-Chome, Minato-Ku, Tokyo 107-8541 Japan (“Asubio”), and Omeros Corporation, a Washington corporation having a principal place of business at 1420 Fifth Avenue, Suite 2600, Seattle, WA 98101 USA (“Omeros”).
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • September 25th, 2020
as of DD MMM, YYYY, is made for and between INSERT COMPANY NAME (“Party A”) with offices at insert address and CLINICAL SERVICE CENTER CO. LTD. 北京科林利康医学研究有限公司 (“Party B”) with offices at Building C01, Main building of Dream 2049 Industrial Park, Courtyard 4, Sanjianfang, Nanli, Chaoyang District, Beijing, 100024, P.R.C.
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • November 7th, 2020 • California
This Confidentiality and Non-Disclosure Agreement (the "Agreement") is made and entered into this day of , 20 , and between UWMI HALIM, LLC. an California Limited Liability Company, with its principal place of business located at San Diego, California, and
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENT (“AGREEMENT”) (Company and UAB)Mutual Confidential Disclosure Agreement • October 9th, 2020
The Parties have caused this Agreement to be executed by their duly authorized representatives as set forth below. This summary and signature page must be used with Exhibit A-Mutual Confidential Disclosure Agreement Terms and Conditions (Company and UAB).
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • March 30th, 2022
WHEREAS, Contractor and LMT desire to disclose to each other confidential and proprietary information, which may include, but not limited to, trade secrets, technical information, ideas, specifications, formulas, drawings, know-how, computer programs, client or third party information, research and development, process information and methods of manufacture, distribution, marketing, strategy and sale, and general business operations, including customer lists, pricing data, financial statements, and business plans, whether in written, oral, electronic, website-based, or other form, (hereinafter referred to as “Confidential Information”) to facilitate consideration of a proposed business relationship there between;
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • October 25th, 2010
WHEREAS, Contractor and LMT Border Assistance desire to disclose to each other confidential and proprietary information, which may include, but not be limited to, trade secrets, technical information, ideas, specifications, formulas, drawings, know-how, computer programs, client or third party information, research and development, process information and methods of manufacture, distribution, marketing, strategy and sale, and general business operations, including customer lists, pricing data, financial statements, and business plans, whether in written, oral, electronic, website-based, or other form, (hereinafter referred to as "Confidential Information") to facilitate consideration of a proposed business relationship there between;
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • September 27th, 2010
This agreement ("Agreement") is entered into by and between Bill Hoolhorst on behalf of Venture Real Estate Partners, and Co-Brokers; Frank Card on behalf of SF Broker Network and
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • September 21st, 2020
This Mutual Confidential Disclosure Agreement (“Agreement”) is entered into as of ___________, between Cold Spring Harbor Laboratory, a New York not-for-profit education corporation, at One Bungtown Road, Cold Spring Harbor, New York 11724 (hereinafter referred to as “CSHL”) and, a _________________________________at _______________________________________________________ (hereinafter referred to as “_______”). CSHL and _____ are interested in conducting certain discussions and negotiations concerning ______________________ (“Commercial Relationship”). This Agreement confirms the terms under which CSHL and _____ in the course of such discussions and negotiations, and for the sole purpose of enabling the parties to evaluate the merits of a possible business agreement or other business relationship, may exchange certain trade secrets and other proprietary and confidential information, including Confidential Information relating to CSHL technologies and inventions.
MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • March 20th, 2019 • Smith & Nephew PLC • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
THIS MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENT (“Agreement”) is effective this 12th day of July, 2018 (“Effective Date”) by and between OSIRIS THERAPEUTICS, INC. having an address at 7015 Albert Einstein Drive, Columbia, Maryland 21046 (“Osiris”) and Smith & Nephew, Inc. with an address located at 1450 E. Brooks Road, Memphis, TN 38116 (“Smith & Nephew”). The parties agree as follows:
